AKRO logo

Akero Therapeutics (AKRO) Total liabilities

annual total liabilities:

$75.77M+$30.81M(+68.52%)
December 31, 2024

Summary

  • As of today (June 28, 2025), AKRO annual total liabilities is $75.77 million, with the most recent change of +$30.81 million (+68.52%) on December 31, 2024.
  • During the last 3 years, AKRO annual total liabilities has risen by +$49.34 million (+186.60%).
  • AKRO annual total liabilities is now -40.37% below its all-time high of $127.07 million, reached on December 31, 2018.

Performance

AKRO Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKRObalance sheet metrics

quarterly total liabilities:

$72.00M-$3.78M(-4.98%)
March 31, 2025

Summary

  • As of today (June 28, 2025), AKRO quarterly total liabilities is $72.00 million, with the most recent change of -$3.78 million (-4.98%) on March 31, 2025.
  • Over the past year, AKRO quarterly total liabilities has increased by +$6.01 million (+9.10%).
  • AKRO quarterly total liabilities is now -43.34% below its all-time high of $127.07 million, reached on December 31, 2018.

Performance

AKRO quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKRObalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

AKRO Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+68.5%+9.1%
3 y3 years+186.6%+208.3%
5 y5 years+706.8%+767.6%

AKRO Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+186.6%-9.1%+208.3%
5 y5-yearat high+706.8%-9.1%+767.6%
alltimeall time-40.4%+1351.0%-43.3%+2894.9%

AKRO Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$72.00M(-5.0%)
Dec 2024
$75.77M(+68.5%)
$75.77M(-4.4%)
Sep 2024
-
$79.22M(+18.3%)
Jun 2024
-
$66.98M(+1.5%)
Mar 2024
-
$65.99M(+46.8%)
Dec 2023
$44.97M(+49.8%)
$44.97M(-13.9%)
Sep 2023
-
$52.20M(+10.2%)
Jun 2023
-
$47.37M(+11.5%)
Mar 2023
-
$42.47M(+41.5%)
Dec 2022
$30.01M(+13.5%)
$30.01M(-16.4%)
Sep 2022
-
$35.90M(-3.8%)
Jun 2022
-
$37.30M(+59.7%)
Mar 2022
-
$23.35M(-11.7%)
DateAnnualQuarterly
Dec 2021
$26.44M(+80.8%)
$26.44M(+6.2%)
Sep 2021
-
$24.91M(+39.3%)
Jun 2021
-
$17.88M(+54.1%)
Mar 2021
-
$11.60M(-20.7%)
Dec 2020
$14.63M(+55.7%)
$14.63M(+7.7%)
Sep 2020
-
$13.58M(+30.6%)
Jun 2020
-
$10.39M(+25.3%)
Mar 2020
-
$8.30M(-11.6%)
Dec 2019
$9.39M(-92.6%)
$9.39M(+39.0%)
Sep 2019
-
$6.76M(+41.4%)
Jun 2019
-
$4.78M(+98.8%)
Mar 2019
-
$2.40M(-98.1%)
Dec 2018
$127.07M(+2333.4%)
$127.07M
Dec 2017
$5.22M
-

FAQ

  • What is Akero Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Akero Therapeutics?
  • What is Akero Therapeutics annual total liabilities year-on-year change?
  • What is Akero Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Akero Therapeutics?
  • What is Akero Therapeutics quarterly total liabilities year-on-year change?

What is Akero Therapeutics annual total liabilities?

The current annual total liabilities of AKRO is $75.77M

What is the all time high annual total liabilities for Akero Therapeutics?

Akero Therapeutics all-time high annual total liabilities is $127.07M

What is Akero Therapeutics annual total liabilities year-on-year change?

Over the past year, AKRO annual total liabilities has changed by +$30.81M (+68.52%)

What is Akero Therapeutics quarterly total liabilities?

The current quarterly total liabilities of AKRO is $72.00M

What is the all time high quarterly total liabilities for Akero Therapeutics?

Akero Therapeutics all-time high quarterly total liabilities is $127.07M

What is Akero Therapeutics quarterly total liabilities year-on-year change?

Over the past year, AKRO quarterly total liabilities has changed by +$6.01M (+9.10%)
On this page